Cargando…

Formulation of Orally Disintegrating Films as an Amorphous Solid Solution of a Poorly Water-Soluble Drug

The objective of the present study was to develop an orally disintegrating film (ODF) for a poorly water-soluble drug, phenytoin (PHT), using the cosolvent solubilization technique to achieve the amorphization of the drug, followed by the preparation of ODFs. Eleven formulations were prepared with d...

Descripción completa

Detalles Bibliográficos
Autores principales: Panraksa, Pattaraporn, Tipduangta, Pratchaya, Jantanasakulwong, Kittisak, Jantrawut, Pensak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759778/
https://www.ncbi.nlm.nih.gov/pubmed/33261025
http://dx.doi.org/10.3390/membranes10120376
_version_ 1783627177017737216
author Panraksa, Pattaraporn
Tipduangta, Pratchaya
Jantanasakulwong, Kittisak
Jantrawut, Pensak
author_facet Panraksa, Pattaraporn
Tipduangta, Pratchaya
Jantanasakulwong, Kittisak
Jantrawut, Pensak
author_sort Panraksa, Pattaraporn
collection PubMed
description The objective of the present study was to develop an orally disintegrating film (ODF) for a poorly water-soluble drug, phenytoin (PHT), using the cosolvent solubilization technique to achieve the amorphization of the drug, followed by the preparation of ODFs. Eleven formulations were prepared with different polymers, such as polyvinyl alcohol (PVA) and high methoxyl pectin (HMP) by the solvent casting method. The prepared films were subjected to characterization for weight variations, thickness, surface pH, disintegration time and mechanical strength properties. Then, differential scanning calorimetry, X-ray diffraction analysis and the drug release patterns of the selected films were evaluated. Among the prepared formulations, the formulation composed of 1% w/w of PVA, 0.04% w/w of sodium starch glycolate with polyethylene glycol 400, glycerin and water as cosolvents (PVA-S4) showed promising results. The physical appearance and mechanical strength properties were found to be good. The PVA-S4 film was clear and colorless with a smooth surface. The surface pH was found to be around 7.47 and the in vitro disintegration time was around 1.44 min. The drug content of the PVA-S4 film was 100.27%. X-ray diffractometry and thermal analysis confirmed the transition of phenytoin in the PVA-S4 film into a partially amorphous state during film preparation using the cosolvent solubilization approach. The resulting PVA-S4 film showed a higher dissolution rate in comparison to the film without a cosolvent. Overall, this study indicated the influence of cosolvents on enhancing the solubility of a poorly water-soluble drug and its film dissolution.
format Online
Article
Text
id pubmed-7759778
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77597782020-12-26 Formulation of Orally Disintegrating Films as an Amorphous Solid Solution of a Poorly Water-Soluble Drug Panraksa, Pattaraporn Tipduangta, Pratchaya Jantanasakulwong, Kittisak Jantrawut, Pensak Membranes (Basel) Article The objective of the present study was to develop an orally disintegrating film (ODF) for a poorly water-soluble drug, phenytoin (PHT), using the cosolvent solubilization technique to achieve the amorphization of the drug, followed by the preparation of ODFs. Eleven formulations were prepared with different polymers, such as polyvinyl alcohol (PVA) and high methoxyl pectin (HMP) by the solvent casting method. The prepared films were subjected to characterization for weight variations, thickness, surface pH, disintegration time and mechanical strength properties. Then, differential scanning calorimetry, X-ray diffraction analysis and the drug release patterns of the selected films were evaluated. Among the prepared formulations, the formulation composed of 1% w/w of PVA, 0.04% w/w of sodium starch glycolate with polyethylene glycol 400, glycerin and water as cosolvents (PVA-S4) showed promising results. The physical appearance and mechanical strength properties were found to be good. The PVA-S4 film was clear and colorless with a smooth surface. The surface pH was found to be around 7.47 and the in vitro disintegration time was around 1.44 min. The drug content of the PVA-S4 film was 100.27%. X-ray diffractometry and thermal analysis confirmed the transition of phenytoin in the PVA-S4 film into a partially amorphous state during film preparation using the cosolvent solubilization approach. The resulting PVA-S4 film showed a higher dissolution rate in comparison to the film without a cosolvent. Overall, this study indicated the influence of cosolvents on enhancing the solubility of a poorly water-soluble drug and its film dissolution. MDPI 2020-11-27 /pmc/articles/PMC7759778/ /pubmed/33261025 http://dx.doi.org/10.3390/membranes10120376 Text en © 2020 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Panraksa, Pattaraporn
Tipduangta, Pratchaya
Jantanasakulwong, Kittisak
Jantrawut, Pensak
Formulation of Orally Disintegrating Films as an Amorphous Solid Solution of a Poorly Water-Soluble Drug
title Formulation of Orally Disintegrating Films as an Amorphous Solid Solution of a Poorly Water-Soluble Drug
title_full Formulation of Orally Disintegrating Films as an Amorphous Solid Solution of a Poorly Water-Soluble Drug
title_fullStr Formulation of Orally Disintegrating Films as an Amorphous Solid Solution of a Poorly Water-Soluble Drug
title_full_unstemmed Formulation of Orally Disintegrating Films as an Amorphous Solid Solution of a Poorly Water-Soluble Drug
title_short Formulation of Orally Disintegrating Films as an Amorphous Solid Solution of a Poorly Water-Soluble Drug
title_sort formulation of orally disintegrating films as an amorphous solid solution of a poorly water-soluble drug
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759778/
https://www.ncbi.nlm.nih.gov/pubmed/33261025
http://dx.doi.org/10.3390/membranes10120376
work_keys_str_mv AT panraksapattaraporn formulationoforallydisintegratingfilmsasanamorphoussolidsolutionofapoorlywatersolubledrug
AT tipduangtapratchaya formulationoforallydisintegratingfilmsasanamorphoussolidsolutionofapoorlywatersolubledrug
AT jantanasakulwongkittisak formulationoforallydisintegratingfilmsasanamorphoussolidsolutionofapoorlywatersolubledrug
AT jantrawutpensak formulationoforallydisintegratingfilmsasanamorphoussolidsolutionofapoorlywatersolubledrug